These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34314827)

  • 1. Microfabricated disk technology: Rapid scale up in midbrain organoid generation.
    Mohamed NV; Lépine P; Lacalle-Aurioles M; Sirois J; Mathur M; Reintsch W; Beitel LK; Fon EA; Durcan TM
    Methods; 2022 Jul; 203():465-477. PubMed ID: 34314827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 3. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
    Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
    Patikas N; Ansari R; Metzakopian E
    Neurosci Res; 2023 Oct; 195():13-28. PubMed ID: 37271312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
    Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
    Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
    Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
    Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon Fibers as a New Type of Scaffold for Midbrain Organoid Development.
    Tejchman A; Znój A; Chlebanowska P; Frączek-Szczypta A; Majka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.
    Jo J; Xiao Y; Sun AX; Cukuroglu E; Tran HD; Göke J; Tan ZY; Saw TY; Tan CP; Lokman H; Lee Y; Kim D; Ko HS; Kim SO; Park JH; Cho NJ; Hyde TM; Kleinman JE; Shin JH; Weinberger DR; Tan EK; Je HS; Ng HH
    Cell Stem Cell; 2016 Aug; 19(2):248-257. PubMed ID: 27476966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to measuring protein turnover in human induced pluripotent stem cell organoids by mass spectrometry.
    Dong J; Duchesne A; Bayne AN; Mohamed NV; Yi W; Mathur M; Chen CXQ; You Z; Abdian N; Taylor L; Fon EA; Durcan TM; Trempe JF
    Methods; 2022 Jul; 203():17-27. PubMed ID: 35331912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality.
    Sabate-Soler S; Nickels SL; Saraiva C; Berger E; Dubonyte U; Barmpa K; Lan YJ; Kouno T; Jarazo J; Robertson G; Sharif J; Koseki H; Thome C; Shin JW; Cowley SA; Schwamborn JC
    Glia; 2022 Jul; 70(7):1267-1288. PubMed ID: 35262217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
    Renner H; Schöler HR; Bruder JM
    Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 16. Uniform cerebral organoid culture on a pillar plate by simple and reproducible spheroid transfer from an ultralow attachment well plate.
    Acharya P; Joshi P; Shrestha S; Choi NY; Jeong S; Lee MY
    Biofabrication; 2024 Jan; 16(2):. PubMed ID: 38176079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Millifluidic culture improves human midbrain organoid vitality and differentiation.
    Berger E; Magliaro C; Paczia N; Monzel AS; Antony P; Linster CL; Bolognin S; Ahluwalia A; Schwamborn JC
    Lab Chip; 2018 Oct; 18(20):3172-3183. PubMed ID: 30204191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Evaluation of Parkinson's Disease Patient-Derived Midbrain Organoids Using Mesoporous Au Nanodot-Patterned 3D Concave Electrode.
    An J; Shin M; Beak G; Yoon J; Kim S; Cho HY; Choi JW
    ACS Sens; 2024 Jul; 9(7):3573-3580. PubMed ID: 38954790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease.
    Galet B; Cheval H; Ravassard P
    Front Neurol; 2020; 11():1005. PubMed ID: 33013664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.
    Smits LM; Schwamborn JC
    Front Cell Dev Biol; 2020; 8():359. PubMed ID: 32509785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.